Global Epilepsy Market: Industry Analysis & Outlook

Transcription

1 Industry Research by Koncept Analytics Global Epilepsy Market: Industry Analysis & Outlook February

2 Executive Summary Epilepsy is a group of neurological diseases characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking. These episodes can result in physical injuries including occasionally broken bones. The medical definition of this disease is as a condition characterized by recurrent (two or more) epileptic seizures, unprovoked by any immediate identified cause. Epilepsy is divided into four main types; idiopathic generalized epilepsy, idiopathic partial epilepsy, symptomatic generalized epilepsy and symptomatic partial epilepsy. The cause of epilepsy can be genetic, a result of other disorders such as tumor or brain injury and due to certain seizure triggers. Epilepsy is treated via antiepileptic drugs, surgery in certain cases and several complementary therapies such as ketogenic diets or neural stimulation. Based upon the drug type, epilepsy market can be divided into three main categories; first generation drugs, second generation drugs and third generation drugs. The global epilepsy market is driven by factors such as development of novel drugs, launch of new drugs in developing regions and prevalence of neural disorders such as meningitis and tumors. This growth is then further spearheaded by increasing healthcare expenses and rising disposable incomes. However, the market growth is hindered by tedious drug approval process, generic erosion and high cost of treatment. Trends such as companies focusing on developing effective therapies for refractory epilepsy and physicians demanding higher efficacy drugs are listed in this report. The report Global Epilepsy Drugs Market: Industry Analysis & Outlook analyzes the development of this market, with focus on the Americas, EMEA and APAC regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Novartis AG., Pfizer Inc., GlaxoSmithKline Plc. and UCB are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global epilepsy drugs market along with the study of the regional markets. 2

3 The increasing efforts of governments and private players in developing niche target therapy for epilepsy have resulted in the expansion of antiepileptic drugs market. Further, the entry of new breed of antiepileptic in developing markets of Asia- Pacific and Latin America region has further accentuated the growth. Global Antiepileptic Drugs Market by Value Forecast ( ) In 2016, the global antiepileptic market was recorded at US$... billion and is expected to reach US$... billion by the end of 2021, growing at a CAGR of nearly %, As of 2016, global branded antiepileptic drugs market was recorded at US$... billion and is anticipated to reach US$... billion mark by the end of 2021, growing at a CAGR of %, As of 2016, the Americas region accounted for % revenue share, followed by EMEA and APAC with % and % shares, respectively. Global Branded Antiepileptic Drugs Market by Value Forecast ( ) Global Antiepileptic Drugs Market by Region (2016) The Americas EMEA APAC 3

4 The global market players are focused on developing new drugs with better disease target mechanism and lesser side effects. The launch of the new drugs will help the companies to avoid risks related to side effects and increase the market penetration. The US Antiepileptic Drugs Market by Value Forecast ( ) The US antiepileptic drugs market is expected to reach US$... billion by the end of 2021, increasing from US$... billion in 2016, growing at a CAGR of nearly %, In 2016, EMEA antiepileptic drugs market was recorded at US$... billion and is expected to reach US$...billion by the end of 2021, growing at an CAGR of %, As of 2016, APAC antiepileptic drugs market was recorded at US$... billion and is forecasted to reach US$... billion mark by the end of 2021, growing at a CAGR of %, EMEA Antiepileptic Drugs Market by Value Forecast ( ) APAC Antiepileptic Drugs Market by Value Forecast ( ) 4

5 Contact Us: Disclaimer This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy. Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P T: M: vikas@konceptanalytics.com 5